Summary of Significant Accounting Policies (Details 3) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2015 USD ($) item	Dec. 31, 2014 USD ($)
Segment information
Number of reportable segments | item			1
Medical Indication Information
Contract manufacturing revenue	$ 2,271		$ 2,271
Total	127,059	$ 114,822	233,492	$ 208,209
Antibiotic
Medical Indication Information
Total	2,828	3,346	5,556	6,349
Cardiovascular
Medical Indication Information
Total	13,082	18,333	21,385	37,272
Central Nervous System
Medical Indication Information
Total	6,077		6,077
Gallstone
Medical Indication Information
Total	18,719	16,719	38,691	28,480
Gastrointestinal
Medical Indication Information
Total	8,617		8,693
Glaucoma
Medical Indication Information
Total	6,543	5,516	13,365	10,207
Gout
Medical Indication Information
Total	83	2,990	148	5,289
Migraine
Medical Indication Information
Total	5,705	6,938	11,247	12,733
Muscle Relaxant
Medical Indication Information
Total	1,393	2,300	3,054	2,640
Obesity
Medical Indication Information
Total	851	953	1,830	1,868
Pain Management
Medical Indication Information
Total	8,074	7,567	16,207	14,222
Respiratory
Medical Indication Information
Total	1,396		1,396
Thyroid Deficiency
Medical Indication Information
Total	37,432	44,535	78,534	77,881
Urinary
Medical Indication Information
Total	3,378		3,593
Other
Medical Indication Information
Total	$ 10,610	$ 5,625	$ 21,445	$ 11,268